Patients should avoid unlicensed IV glutathione 'wellness' infusions offered privately due to potential safety risks
86 In the MAPP research study, Hunner lesions were found in 4.0% of cystoscopy in patients less than 50 years old, 19.7% between ages 50 to 70, and 54.5% over the age of 70
Unlike injections, which focus on delivering a single vitamin or nutrient, infusions provide a combination of vitamins, minerals, and other nutrients to support overall health
Nat Commun (2020) 11(1):4767
Common Side Effects (Both Peptides) Mild injection site irritation (redness, minor swelling) Headache (typically early in treatment) Temporary flushing or warmth after injection Mild changes in appetite When Medical Evaluation Is Essential Peptide therapy should always be preceded by: Comprehensive symptom assessment Medical and medication history review Baseline laboratory testing (IGF-1, metabolic panel, hormonal markers) Evaluation for contraindications (active malignancies, certain pituitary conditions) Ongoing monitoring includes periodic IGF-1 testing, symptom tracking, and dosage adjustments based on clinical response
